V. Mariano

Switching from twice-daily glargine or detemir to once-daily degludec improves glucose control in type 1 diabetes. An observational study.

A. Maran, D. Bruttomesso, A. Avogaro, 2016, Nutrition, metabolism, and cardiovascular diseases : NMCD.

Optimized glycaemic control achieved with add‐on basal insulin therapy improves indexes of endothelial damage and regeneration in type 2 diabetic patients with macroangiopathy: a randomized crossover trial comparing detemir versus glargine

M. Marescotti, A. Avogaro, A. Tiengo, 2011, Diabetes, obesity & metabolism.

Vitamin D status and non-alcoholic fatty liver disease in patients with type 1 diabetes

D. Bruttomesso, M. Marescotti, A. Avogaro, 2019, Journal of Endocrinological Investigation.

Influence of health locus of control and fear of hypoglycaemia on glycaemic control and treatment satisfaction in people with Type 1 diabetes on insulin pump therapy

E. Bonora, D. Bruttomesso, A. Avogaro, 2017, Diabetic medicine : a journal of the British Diabetic Association.